Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
83 results about "Chlamydiae" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The Chlamydiae are bacterial phylum and class whose members are a group of obligate intracellular bacteria, whose members are remarkably diverse, ranging from pathogens of humans and animals to symbionts of ubiquitous protozoa. They are ovoid in shape and stain Gram-negative. Historically it was believed that all Chlamydiae species had a peptidoglycan-free cell wall, but recent work demonstrates a detectable presence of peptidoglycan, as well as other important proteins. Many species belonging to this order are susceptible to antimicrobial agents. All known Chlamydiae only grow by infecting eukaryotic host cells. They are as small as or smaller than many viruses. They are dependent on replication inside the host cells, thus some species are termed obligate intracellular pathogens and others are symbionts of ubiquitous protozoa. Most intracellular Chlamydiae are located in an inclusion body or vacuole. Outside cells, they survive only as an extracellular infectious form. Chlamydiae can grow only where their host cells grow, and develop according to a characteristic biphasic developmental cycle. Therefore, Chlamydiae cannot be propagated in bacterial culture media in the clinical laboratory. Chlamydiae are most successfully isolated while still inside their host cells. Chlamydiae is the most common bacterial STD in the United States and 2.86 million chlamydiae infections are reported annually.
Methods for sterilizing biological materials by irradiation over a temperature gradient
InactiveUS6908591B2Effective sterilizationImprove permeabilityDead animal preservationLavatory sanitoryBiological materialsBiology
Methods are disclosed for sterilizing tissue to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, spores, prions or similar agents responsible, alone or in combination, for TSEs and / or single or multicellular parasites. The methods involve sterilizing one or more tissues with irradiation.
Owner:CLEARANT
Nanosilver-containing antibacterial and antifungal granules and methods for preparing and using the same
Owner:LEGEND WIN FINANCE
Chlamydia antigens and corresponding DNA fragments and uses thereof
The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding full-length, 5′-truncated or 3′-truncated 76 kDa protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the 76 kDa protein gene in the host. Modifications are possible within the scope of this invention.
Owner:SANOFI PASTEUR LTD
Chlamydia antigens and corresponding DNA fragments and uses thereof
The present invention provides nucleic acids, proteins and vectors for a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The method employs a vector containing a nucleotide sequence encoding a transmembrane protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the transmembrane protein gene product in the host. Modifications are possible within the scope of this invention.
Owner:AVENTIS PASTEUR LTD
Fluorescence PCR method for diagnosing infection of Chlamydia trachomatis, neisseria gonorrhoeae and ureaplasma urealyticum
ActiveCN101613763AMicrobiological testing/measurementMicroorganism based processesForward primerFluorescence
The invention relates to a fluorescence PCR (polymerase chain reaction) detection method for diagnosing infection of Chlamydia trachomatis (CT), neisseria gonorrhoeae (NG) and ureaplasma urealyticum (UU), which belongs to the field of nucleic acid in vitro diagnosis. The method comprises a polymerase chain reaction (PCR) system based on fluorescence PCR technology, contains a forward primer and areverse primer aiming at the CT / the NG / the UU and a fluorescent probe, and can detects DNA of three pathogens such as the CT, the NG, the UU and the like simultaneously in a reaction tub under suitable PCR condition. The method can diagnosing the infection of the CT / the NG / the UU in a clinical sample simply, conveniently and rapidly, has high sensitivity and specificity, and has important clinical value to early control and prevention of relevant genitourinary tract infections, blocking of an infection sources, and infection reduction of related pathogen.
Owner:CITY UNIVERSITY OF HONG KONG
Chlamydia pmp proteins, gene sequences and uses thereof
InactiveUS20040037846A1Compounds screening/testingAntibacterial agentsChlamydiaceae InfectionsNucleotide
The invention discloses the Chlamydia PMPE and PMPI polypeptide, polypeptides derived therefrp, (PMP-derived polypeptides), nucleotide sequences encoding said polypeptides, antibodies that specifically bind the PMP polypeptides and PMP-derived polypeptides and T-cells specific for PMP polypeptides and PMP-derived polypeptides. Also disclosed are prophylactic and therapeutic compositions, including immunogenic compositions, e.g., vaccines, comprising PMP polypeptides or PMP-derived polypeptides or antibodies thereto. The invention additionally discloses methods of inducing in animals an immune response to Chlamydia cells, Chlamydia elementary bodies, and / or cells expressing Chlamydial proteins, e.g., cell infected with Chlamydia.
Owner:EMERGENT PROD DEV GAITHERSBURG INC
Staining kit and preparation method, staining method, and use thereof
InactiveCN1434127AMany inspection itemsPlay a role in promotingMicrobiological testing/measurementDiseaseStaining
The present invention relates to a staining kit and its preparation method, staining method and its application in several detection items for detecting canceration cell, red blood cell, campylobacteriosis, vaginal cleaning degree, estrogen level, garlandosus, trichomoniasis, mycosis, diplococcus gonorrhoeae and chlamydi trachomatis on a cervical smear. Said invented kit is formed from fixatino fluid, staining solution and differentiatino solution. Its staining method includes the steps of fixation, staining, differentiation and water-washing. Its film-making speed is quick, only has need oftwo main, and its detection accuracy rate is high, can be up to 98%.
Owner:裴芳君
Chlamydia trachomatis antigens for vaccine and diagnostic use
InactiveUS20090304722A1High expressionImprove abilitiesAntibacterial agentsOrganic active ingredientsGamma interferonWhole cell lysate
The present invention is related to antigens from Chlamydia trachomatis which are recognized by specific antibodies from individuals infected with Chlamydia or which can induce T cells from the same individuals to secrete gamma-interferon. The T cell reactive antigens are present in a whole-cell lysate and have apparent molecular weights of 5-12, 16-20, 25-35 and 58-74 kDa as determined by SDS-PAGE. The antigens of the invention are useful in vaccines but also as diagnostic compositions.
Owner:STATENS SERUM INST
Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
The present invention relates to secreted Chlamydia polypeptides, which may be expressed by a Gram-negative bacterial strain and secreted by the type III secretion pathway of said bacterial strain. The present invention also relates to polynucleotides coding for these polypeptides, as well as to the therapeutic and vaccination uses of these secreted Chlamydia polypeptides.
Owner:INST PASTEUR +1
Chlamydia pneumoniae IgM (immunoglobulin M) colloidal golden method kit and preparation method thereof
InactiveCN102749446AObvious detectabilityReduce the effectMaterial analysisMurine antibodyChlamydiae
The invention discloses a chlamydia pneumoniae IgM (immunoglobulin M) colloidal golden method kit which comprises recombinant chlamydia pneumoniae antigens enveloped on a nitrocellulose membrane detection line, goat anti-rat IgG (immunoglobulin G) antibodies enveloped on a quality control line and rat anti-human IgM monoclonal antibodies which have colloidal gold labels and are enveloped on a gold label pad, the concentration of the chlamydia pneumoniae antigens ranges from 1mg / ml to 2mg / ml and is measured by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis), the concentration of the goat anti-rat IgG (immunoglobulin G) antibodies ranges from 1mg / ml to 3mg / ml, and the concentration of the rat anti-human IgM monoclonal antibodies ranges from 5g / mL to 30g / mL and is measured by the SDS-PAGE. The chlamydia pneumoniae IgM colloidal golden method kit has the advantages that the kid is speedy, simple, convenient and accurate and is high in sensitivity, and a judgment result can be read after integral operation time of dozens of minutes; and a colloidal gold quick detecting paper strip is made of the multi-epitope recombinant antigens and is simple and convenient to operate, low in cost, good in specificity and high in sensitivity, can be used for single-component detection and is popularized easily, and detection and control effects for chlamydia pneumoniae IgM are obvious.
Owner:北京中检安泰诊断科技有限公司
Primer, probe, kit and detection method for multiple detection of chlamydia trachomatis, neisseria gonorrhoeae and ureaplasma
InactiveCN109825615AImprove accuracyHigh sensitivityMicrobiological testing/measurementDNA/RNA fragmentationPathogenic microorganismFluorescence
The invention relates to the technical field of detection of pathogenic microorganisms, in particular to primers, a probe, a kit and a detection method for multiple detection of chlamydia trachomatis,neisseria gonorrhoeae and ureaplasma. The kit comprises a CT / NG / UU conserved region-specific primer pair and the Taqman fluorescent probe. The kit can accurately detect CT / NG / UU infected samples by real-time fluorescent quantitative PCR, and is convenient and quick to use, high in sensitivity, good in specificity and high in repeatability.
Owner:中生方政生物技术股份有限公司
Methods of detecting chlamydia and gonorrhea and of screening for infection/inflammation based on genomic copy number
ActiveUS20160257998A1Microbiological testing/measurementAntiinfectivesNucleic acid sequencingChlamydiae
Compositions and methods for detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are provided. The present invention also provides methods and compositions for screening for infection / inflammation based on genomic copy number. Described herein is a method that entails assaying a sample obtained from the urogenital tract of the mammal for an indicator of genomic copy number, wherein a genomic copy number level that is higher than a control genomic copy number level is indicative of the presence of infection or inflammation of the urogenital tract. Also described in a kit of the invention that includes a primer and / or probe for detecting or sequencing an indicator of genomic copy number, wherein the indicator of genomic copy number comprises a nucleic acid sequence that is expected to be present in the genome of the mammal in one or two copies; and a primer and / or probe for detecting or sequencing a nucleic acid sequence that is indicative of a pathogen that infects the urogenital tract or a miRNA correlated with inflammation.
Owner:CEPHEID INC
Bivalent inactivated vaccine for goat mycoplasma pneumonia and chlamydia psittaci disease and preparation method thereof
ActiveCN111789941AAvoid infectionImprove securityAntibacterial agentsBacterial antigen ingredientsChlamydia psittaci infectionsMycoplasma pneumonia
The invention discloses a bivalent inactivated vaccine for goat mycoplasma pneumonia and chlamydia psittaci and a preparation method thereof. The active ingredients of the bivalent inactivated vaccinecomprise inactivated Mycoplasma capricolum subsp. Capripneumoniae, inactivated mycoplasma ovipneumoniae and inactivated MOMP protein of chlamydia psittaci. The amino acid sequence of the MOMP proteinof the chlamydia psittaci is shown as a sequence 2 in a sequence table. The mycoplasma ovipneumoniae is mycoplasma ovipneumoniae SH-01 CGMCC No.16503. The Mycoplasma capricolum subsp. Capripneumoniaeis Mycoplasma capricolum subsp. Capripneumoniae GT-01 CGMCC No.16504. Experiments prove that the bivalent inactivated vaccine has good safety in immunizing experimental animals and target animals, and can effectively prevent goat mycoplasma pneumonia and chlamydia psittaci from infecting the experimental animals and the target animals. The vaccine has important significance for preventing and controlling prevalence and propagation of mycoplasma pneumonia and chlamydia psittaci of goats. The vaccine has important application value.
Owner:INNER MONGOLIA HUAXI BIOTECH
Pathogen nucleic acid-drug resistant gene detection kit and application thereof
ActiveCN104513854AHigh sensitivityStrong specificityMicrobiological testing/measurementMicroorganism based processesMycoplasma hominisChlamydiae
The invention relates to the technical field of medical biology, and especially relates to a pathogen nucleic acid-drug resistant gene detection kit and an application technology thereof. The kit designed by the invention includes the following two kinds of compositions: a PCR reaction buffer solution, an enzyme mixed solution, and a chlamydia trachomatis / mycoplasma urealytium / mycoplasma hominis / drug resistant gene multiple reaction solution; or a PCR reaction buffer solution, an enzyme mixed solution, a chlamydia trachomatis / mycoplasma urealytium / mycoplasma hominis multiple reaction solution, and a drug resistant gene reaction liquid. The kit adopts a multi-fluorescence quantitative PCR technology, can simultaneously detect multiple target genes in a same PCR reaction tube, and provides a powerful technical support for simultaneous detection of pathogens and drug resistant genes. A method has the characteristics of less required amount on samples, low cost, simple and convenient operation, high sensitivity and good specificity, and has extremely great social and economic significances.
Owner:常州百代生物科技股份有限公司
Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
The invention discloses the Chlamydia PMPE and PMPI polypeptide, polypeptides derived therefor, (PMP-derived polypeptides), nucleotide sequences encoding said polypeptides, antibodies that specifically bind the PMP polypeptides and PMP-derived polypeptides and T-cells specific for PMP polypeptides and PMP-derived polypeptides. Also disclosed are prophylactic and therapeutic compositions, including immunogenic compositions, e.g., vaccines, comprising PMP polypeptides or PMP-derived polypeptides or antibodies thereto. The invention additionally discloses methods of inducing in animals an immune response to Chlamydia cells, Chlamydia elementary bodies, and / or cells expressing Chlamydial proteins, e.g., cell infected with Chlamydia.
Owner:EMERGENT PROD DEV GAITHERSBURG INC
Nano-gold test paper for detecting major outer membrane protein antigen of chlamydia trachomatis as well as preparation method and application thereof
InactiveCN102411055AHigh sensitivityEasy to storeMaterial analysisNitrocelluloseChlamydia trachomatis Antigen
The invention relates to test paper for detecting chlamydia trachomatis infection, and the test paper comprises a baseplate, a sample pad, a conjugate pad, a nitrocellulose membrane and an absorption pad, wherein a detection line and a quality control line are arranged on the nitrocellulose membrane, the detection line on the nitrocellulose membrane is coated by mouse anti-human monoclonal protein antibody IgG (antibody II) of major outer membrane protein antigen of chlamydia trachomatis in the concentration of greater than or equal to 1mg / mL, and the quality control line is coated by goat anti-mouse IgG polyclonal antibody in the concentration of greater than or equal to 1.5mg / mL; the conjugate pad is coated by mouse anti-human monoclonal protein antibody IgG (antibody I) of the MOMP (major outer membrane protein) antigen of the chlamydia trachomatis, which is labeled by nano-gold and is in the concentration of not less than 6 mu g / mL; the sensitivity of detecting the MOMP of the chlamydia trachomatis of the test paper is 0.1ng / ml, the detection value range is 0-200ng / ml and the specificity is 98.5%; and the detection can be completed within 5 minutes.
Owner:ARMY MEDICAL UNIV
A chlamydiae pneumoniae IgM chemiluminescent immunoassay kit and a preparing method thereof
InactiveCN106404754ALow costHigh detection sensitivityChemiluminescene/bioluminescenceIgm antibodyChemiluminescent immunoassay
A chlamydiae pneumoniae IgM chemiluminescent immunoassay kit is disclosed. The kit includes magnetic micro-particles coated with a chlamydiae pneumoniae antigen, an acridinium ester labeled mouse anti-human IgM antibody, a chlamydiae pneumoniae IgM calibrated product, a pre-excitation liquid and an excitation liquid. The invention also discloses a preparing method of the kit. Compared with kits at present, the kit has advantages of simple and convenient operation, high sensitivity, a wide detection range, and the like.
Owner:SHENZHEN YHLO BIOTECH
Degerming dustproof multifunctional electronic mask
PendingCN111869962AExcellent filtration efficiencyGuaranteed temperatureDeodrantsProtective garmentFiberCarbon fibers
A degerming dustproof a multifunctional electronic mask is characterized in that an outer layer body 1, an inner layer body 2, an isolation layer 3, an air hole 4, an air hole 5, an air hole 6, a negative electrode 7, an adsorption body 8, a positive electrode 9, an adsorption body 10, a supporting body 11, ear bands 12, a power supply 13 and a zipper 14 are connected into a whole to form the degerming and dustproof multifunctional electronic mask. The degerming dustproof multifunctional electronic mask which is wide in degerming range and various in dustproof variety. Degerming comprises non-cell microorganisms (various viruses); prokaryotic cell type microorganisms (various bacteria, mycoplasma, chlamydia, rickettsia, spirochete and actinomycetes); eukaryotic cell type microorganisms (fungi) and various bacterial spores. Dust prevention includes a variety of oily, non-oily contaminants in air from particles greater than 5 microns to particles less than 1 micron. The degerming dustproof multifunctional electronic mask is suitable for medical treatment and public health, production labor, household protection, fitness and physical exercise. The degerming dustproof multifunctional electronic mask is wide in manufacturing material and low in production cost, the mask body is made of elastic non-breathable ultrathin insulating material fibers, fabrics and films, the electrodes aremade of metal sheets, metal coating films or conductive carbon fibers, and the adsorption body is made of paper fibers (used in dry seasons in winter) or chemical fibers (used in rainy seasons in summer). The power supply is a general mobile phone lithium battery and a high-voltage electron generator.
Owner:肖英佳
Traditional Chinese medicine composition gelata for treating gynecological inflammations
InactiveCN102485245AEnhanced inhibitory effectRecovery of vaginal self-cleaning functionAntibacterial agentsAntimycoticsProtozoaDisease
Owner:ZHUZHOU QIANJIN PHARMA
Immunogenic compositions for Chlamydia trachomatis
InactiveUS20110158977A1Improved immunogenic compositionSimple compositionAntibacterial agentsOrganic active ingredientsChlamydiaceae InfectionsSerotype
The present invention provides variant LcrE sequences and / or combinations of variant LcrE sequences across the Chlamydia trachomatis serovars. Such changes in LcrE genotypes across the Chlamydia trachomatis serovars are likely to correspond with changes in LcrE phenotypes, in particular, with changes in immunogenicity. The present invention also provides peptides surrounding or associated with the amino acid substitutions, in particular, peptides surrounding or associated with high frequency mutated amino acid positions or hypervariable regions, which are likely to be B and / or T cell epitopic regions capable of eliciting Chlamydia specific cell mediated immune responses. The variant LcrE sequences and / or combinations of the variant LcrE sequences and / or epitope regions associated with the variant LcrE sequences are useful as immunogens and / or in the preparation of immunogenic compositions for preventing and / or treating and / or, diagnosing Chlamydia infections.
Owner:CHIRON CORP
Primer set for triple detection of Neisseria gonorrhoeae, Chlamydia trachomatis and Ureaplasma urealyticum, product and application
InactiveCN111471781AHigh sensitivityStrong specificityMicrobiological testing/measurementMicroorganism based processesUreaplasma urealyticumChlamydiae
The invention provides a primer set for the triple detection of Neisseria gonorrhoeae, Chlamydia trachomatis and Ureaplasma urealyticum, a product and an application, and relates to the technical field of molecular biology. The primer set provided by the invention includes a primer pair for detecting Neisseria gonorrhoeae, a primer pair for detecting Chlamydia trachomatis, and a primer pair for detecting Ureaplasma urealyticum, the simultaneous detection of three pathogens of Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), and Ureaplasma urealyticum (UU) in one detection system is realized, and the primer set provided by the invention also has the advantages such as high sensitivity, good specificity, strong reproducibility, and rapid and intuitive detection results.
Owner:HANGZHOU BIOER TECH CO LTD
Silver ion antibacterial gel and preparation method thereof
InactiveCN106074783AReasonable formulaEasy to makeAntibacterial agentsAntimycoticsGlycerolSilver ion
The invention provides a silver ion antibacterial gel. The silver ion antibacterial gel is prepared from, by mass, 0.5-0.6 part of soluble silver salt, 7-8 parts of carbomer, 50-150 parts of propylene glycol, 50-150 parts of glycerin, 15-20 parts of menthol, 15-20 parts of radix sophorae flavescentis, 3-15 parts of peach kernels and 10-20 parts of herba taraxaci. The silver ion antibacterial gel is reasonable in formula and easy to prepare and has a strong killing effect on pathogenic microorganisms such as bacteria, fungi, candida, viruses, mycoplasmas and chlamydiae. The silver ion antibacterial gel is suitable for gynecological inflammations and vaginal infections caused by the various pathogenic microorganisms.
Owner:刘之伟
Recombination protein for preventing human trachoma bedsnia infestation and its use
InactiveCN1478549APeptide/protein ingredientsAntibody mimetics/scaffoldsCell Membrane ProteinsHeat shock protein
A recombinant protein vaccine for preventing the infection of human chlamydia trachomatis, which is a fusion protein recombined by linking the heat shock protein 65 of BCG vaccine with the epitope of main outer membrane protein of chlamydia trachomatis, the nucleotide sequence for coding it, the expression carrier containing said nucleotide sequence, the host cell containing said expression carrier, and the process for preparing said recombinant protein vaccine are disclosed.
Owner:BEIJING HYDVAX BIOTECH
Kit for rapidly detecting urogenital tract pathogens
InactiveCN111647672ARealize synchronous detectionQuick checkMicrobiological testing/measurementMicroorganism based processesUreaplasma urealyticumChlamydiae
The invention provides a kit for rapidly detecting urogenital tract pathogens. The kit is characterized by comprising PCR reaction liquid, Taq / UDG enzyme mixture liquid, positive control and negativecontrol; the PCR reaction liquid comprises 10*PCR buffer, a primer and a probe of chlamydia trachomatis CT, a primer and a probe of gonococcus NG, a primer and a probe of ureaplasma urealyticum UU, aprimer and a probe of human beta-globin HBB, 25 mM MgCl<2>, dNTPs (dATP, dGTP, dCTP, dTTP, dUTP mixtures), and sterile distilled water. The kit in the invention has the advantages that: sample nucleicacid does not need to be extracted; detection is carried out after direct treatment; operation is simple, convenient and rapid; a single tube can detect multiple pathogens at the same time; the kit is economic and high-efficiency; high-flux sample detection can be carried out; the detection efficiency is increased; and the kit is good in specificity, high in pollution and interference resistance,good in result repeatability, and relatively precise.
Owner:安徽同科生物科技有限公司
Composition for treating sow reproductive system infection and preparation method thereof
InactiveCN103417553APromote recoverySpeed up recoveryAntibacterial agentsAntipyreticAnaerobic bacteriaAdditive ingredient
The invention discloses a composition for treating sow reproductive system infection and a preparation method thereof. The composition comprises, by weight, 5-15% of doxycycline hydrochloride, 10-30% of dimetronidazole, 5-15% of taurine and the balance anhydrous dextrose. The doxycycline hydrochloride and the dimetronidazole are used as antibiotic ingredients and make up for the defect of pathogenic microorganism resistant ranges of the doxycycline hydrochloride and the dimetronidazole, are effective in gram-positive bacteria, gram-negative bacteria, mycoplasmas, chlamydiae, spirochetes, trichomonads, anaerobic bacteria and the like, and avoid therapeutic errors. The taurine reduces inflammatory reaction after infection, controls body temperature effectively, reduces pessimal stimulation after attack and speeds up recovery. The composition combining the doxycycline hydrochloride, the dimetronidazole and the taurine improves the cure rate of sow reproductive system infection, speeds up recovery, and facilitates sow recovery.
Owner:TIANJIN SHENGJI GRP CO LTD
Combined device and detection method for synchronously detecting influenza A virus, influenza B virus, chlamydia pneumoniae IgM antibody and mycoplasma IgM antibody
PendingCN111610329ASynchronize independent test resultsIndependent Testing ProcessMaterial analysisReceptorIgm antibody
The invention belongs to the field of medical detection equipment, and provides a combined device for synchronously detecting IgM antibodies of influenza A and B viruses and chlamydia pneumoniae and mycoplasma pneumoniae. The device comprises a double-channel clamping shell, a test strip FluA & B and a test strip CP & MP which are arranged in the double-channel clamping shell in parallel; influenza virus A detection lines arranged on a nitrocellulose membrane of the test strip FluA & B at intervals are coated with high-specificity influenza virus A antigens, influenza virus B detection linesare coated with high-specificity influenza virus B antigens, and first quality control lines are coated with quality control line coating receptors; chlamydia pneumoniae detection lines (CP) arranged on a nitrocellulose membrane of the test strip CP & MP at intervals are coated with high-specificity chlamydia pneumoniae antigens, mycoplasma pneumoniae detection lines (MP) are coated with high-specificity mycoplasma pneumoniae antigens, and second quality control lines are coated with quality control line coating receptors.
Owner:北京柏兆嘉业科技有限公司
Bactericidal wearable instrument panel or camera window and manufacturing method for bactericidal wearable instrument
InactiveCN105441944AImprove compactnessStrong adhesionVacuum evaporation coatingSputtering coatingPathogenic microorganismEscherichia coli
The invention discloses a bactericidal instrument panel or camera window and a manufacturing method for the wearable instrument panel or camera window. The bactericidal instrument panel or camera window comprises a substrate, wherein the outer surface of the substrate is sequentially provided with a first film layer, a second film layer and a third film layer from inside to outside; the first film layer is a nano silver layer with a thickness of 5-20nm; and the second film layer is a hard-hardness layer with a thickness of 10-50nm. According to the technical scheme, the first film layer is the nano sliver layer which has strong inhibiting and killing effects on ten pathogenic microorganisms such as escherichia coli, gonococci, chlamydia trachomatis and the like without generating drug tolerance; the thickness of the first film layer is 5-20nm, so that enough bactericidal ability of the instrument panel or camera window is guaranteed; the second film layer is the high-hardness layer, so that the instrument panel or camera window has the wearable effect; and the thickness of the second film layer is 10-50nm, so that enough wear resistance of the instrument panel or camera window is guaranteed. The bactericidal instrument panel or camera window is reasonable design and high in practicability.
Owner:OURLOOK ZHANGZHOU OPTICAL TECH
Application of Chinese medicinal composition in preparing gel for treating gynecological inflammation
InactiveCN102485244AEnhanced inhibitory effectHydroxy compound active ingredientsPharmaceutical delivery mechanismProtozoaBacterial vaginosis
The invention relates to application of a Chinese medicinal composition in preparing a gel for treating gynecological inflammation, wherein, the Chinese medicinal composition is prepared by the following bulk medicines by weight: 2000 parts of cortex ailanthi, 1500 parts of sophora flavescens, 1500 parts of frankincense, 50 parts of borneol, and 1500 parts of cortex moutan. The gel prepared by the Chinese medicinal composition in the invention can overcome many defects of chemical medicines, exert the incomparable extensive curative effects (such as heat clearing and dehumidifying, leucorrhea stopping and itching relieving, necrotic tissue removing and granulation promoting) of chemical medicines, and can be widely applied in treating gynecological inflammation (such as damp-heat pouring downward leukorrhagia including bacterial vaginosis, vulvovaginal candidiasis, etc.) caused by bacteria, fungi, protozoa, chlamydiae, mycoplasmas and other pathogens.
Owner:ZHUZHOU QIANJIN PHARMA
Joint detection kit for two pathogenic bacteria of gonococcus and chlamydia trachomatis
PendingCN113281508AEasy to operateFew accessoriesBiological testingImmunoassaysMicrobiologyPathogenic bacteria
The invention relates to a joint detection kit for two pathogenic bacteria of gonococcus and chlamydia trachomatis, wherein the joint detection kit comprises a detection card and a lysate; the detection card comprises a gonococcus detection test strip and a chlamydia trachomatis detection test strip; the gonococcus detection test strip and the chlamydia trachomatis detection test strip both comprise sample pads; and the lysate comprises 0.05-0.15 M of a NaOH solution, 0.15 M of a Na2HPO4 solution, 0.005-0.01% by mass of NP40 and 0.005-0.01% by mass of X-100. The lysate adopted in the kit is alkaline, the sample pads of the two pathogenic bacteria are acidic, one-time sampling and one-time sample treatment are achieved by changing the components of treating fluids of the two sample pads, detection of the two pathogenic bacteria is completed at the same time, and operation is convenient and rapid.
Owner:山东康华生物医疗科技股份有限公司
Compositions for treating infective arterial diseases and related conditions
PendingUS20210052557A1Enhance host defence mechanismAntibacterial agentsTetracycline active ingredientsDiseaseMycoplasma penetrans
In alternative embodiments, provided are pharmaceutical compositions and methods for treatment, amelioration and prevention of infection-associated blood vessel diseases, and also for the treatment, amelioration and prevention of non-vessel diseases affected by infective agents which can be treated by these compositions. In alternative embodiments, one common pathogen targeted by compositions and methods as provided herein is Chlamydia and Chlamydophila species, including pneumoniae, trachomatis and psittaci species which infect humans, including Chlamydophila penumoniae which also infects humans. In alternative embodiments, pathogens targeted and infections (diseases) treated ameliorated, or prevented by compositions and methods as provided herein include Mycoplasma, Listeria, Leptospirosis, Q fever or Coxiella burnetii infection, Lyme disease or Lyme borreliosis or any Borrelia infection, and Bartonella or of the family Bartonellaceae, including cat scratch disease.
Owner:CENT FOR DIGESTIVE DISEASES PTY LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com